HCP1102

DRUG2 trials

Sponsors

Hanmi Pharmaceutical Company Limited

Conditions

Perennial Allergic RhinitisRhinitis

Phase 1

Study to Evaluate the Pharmacokinetics and Safety of Singulair and Xyzal in Free Combination and Fixed-dose Combination

CompletedNCT01651481

Hanmi Pharmaceutical Company LimitedRhinitis

Start: 2012-07-31End: 2012-12-31Updated: 2013-08-13

Phase 3

Efficacy and Safety of HCP1102 Capsule in Patients With Perennial Allergic Rhinitis

CompletedNCT04324918

Hanmi Pharmaceutical Company LimitedPerennial Allergic Rhinitis

Start: 2018-10-23End: 2019-06-24Updated: 2020-03-27